Endocrinology

>

Latest News

Positive data: Navepegritide, lonapegsomatropin combination treatment for children with achondroplasia | Image Credit: © lexiconimages - © lexiconimages - stock.adobe.com.
Positive data: Navepegritide, lonapegsomatropin combination treatment for children with achondroplasia

June 9th 2025

The combination therapy yielded boosted treatment benefits of navepegritide, including improvement in mean ACH Z-score and mean annualized growth.

FDA accepts navepegritide application to treat children with achondroplasia | Image credit: Contemporary Pediatrics
FDA accepts navepegritide application to treat children with achondroplasia

June 2nd 2025

FDA approves hydrocortisone oral solution for children 5 years, older with adrenocortical insufficiency | Image credit: Contemporary Pediatrics
FDA approves hydrocortisone oral solution for children 5 years, older with adrenocortical insufficiency

May 29th 2025

Phase 3 data show effectiveness of somapacitan in children with growth disorders | Image Credit: © Saiful52- © Saiful52 - stock.adobe.com.
Phase 3 data show effectiveness of somapacitan in children with growth disorders

May 15th 2025

Puberty discussion with adults and child | Image Credit: © fizkes - stock.adobe.com.
Poll shows many parents unsure when to talk to kids about puberty

April 22nd 2025

Latest CME Events & Activities

Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care

View More

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

View More

<123
© 2025 MJH Life Sciences

All rights reserved.